Ajit Bharti founder of Predictus Biosciences - Predictus BioSciences is developing in-vitro diagnostic tests for cancer.

Predictus BioSciences is developing in-vitro diagnostic tests for cancer. Two FDA-approved CPT analogs, topotecan, and irinotecan are used in the tests. The company provides a molecular mechanism of topoI degradation by UPP and identified the molecular determinants of this pathway.

 

Company Profile Link - https://www.startupsteroid.com/founder?founderUserId=00D76EB1-8533-4DFA-9DD4-3E4AFCD0CC1B